Regulatory actions for March 19, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: J&J, Jenavalve, Mammotmoe, Myriad, Peijia, Roche, Sanofi, Spinal Elements.
Bioworld
via Bioworld
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Provider consolidation slammed in latest House affordability hearing
Next
M.T.A. Aims to Replace Thousands of Aging Subway Cars Built in the 1980s
Related Articles
ScienceA new study questions when people first reached South America
Science News-12h ago-1 sources
ScienceWhen did plate tectonics on Earth begin? New research finds some of the earliest clues
Scientificamerican-12h ago-1 sources
SciencePromising Biotech Stocks To Follow Now – March 19th
The Lincolnian Online-12h ago-1 sources